Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment.
Gröne
D
D
Department of Dermatology, Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany.
Treudler
R
R
de Villiers
E M
EM
Husak
R
R
Orfanos
C E
CE
Zouboulis
Ch C
ChC
D000328:Adult; D000998:Antiviral Agents / Q000600:supply & distribution*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D005260:Female; D006225:Hand / Q000473:pathology; D006801:Humans; D007262:Infusions, Intravenous; D009190:Myelodysplastic Syndromes; D063065:Organophosphonates / Q000008:administration & dosage*; D012871:Skin Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D014860:Warts / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology
D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir